LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | CP724714 | 0.04 | uM | LJP5 | 1 | A12 | 72 | hr | 929 | 3240 | 3228 | 1.0037 | 1.0052 |
Hs 578T | CP724714 | 0.04 | uM | LJP5 | 2 | A12 | 72 | hr | 929 | 3173 | 3228 | 0.9829 | 0.9761 |
Hs 578T | CP724714 | 0.04 | uM | LJP5 | 3 | A12 | 72 | hr | 929 | 3111 | 3228 | 0.9637 | 0.9491 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 1 | I12 | 72 | hr | 929 | 3292 | 3228 | 1.0198 | 1.0278 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 2 | I12 | 72 | hr | 929 | 3362 | 3228 | 1.0415 | 1.0583 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 3 | I12 | 72 | hr | 929 | 3412 | 3228 | 1.0570 | 1.0800 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 929 | 3211 | 3228 | 0.9947 | 0.9926 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 929 | 3033 | 3228 | 0.9396 | 0.9152 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 3 | A24 | 72 | hr | 929 | 3209 | 3228 | 0.9941 | 0.9917 |
Hs 578T | Momelotinib | 0.04 | uM | LJP5 | 1 | P12 | 72 | hr | 929 | 2967 | 3228 | 0.9191 | 0.8864 |
Hs 578T | Momelotinib | 0.04 | uM | LJP5 | 2 | P12 | 72 | hr | 929 | 2803 | 3228 | 0.8683 | 0.8151 |
Hs 578T | Momelotinib | 0.04 | uM | LJP5 | 3 | P12 | 72 | hr | 929 | 3048 | 3228 | 0.9442 | 0.9217 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 929 | 2299 | 3228 | 0.7122 | 0.5959 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 929 | 2260 | 3228 | 0.7001 | 0.5789 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 929 | 2288 | 3228 | 0.7088 | 0.5911 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 929 | 1481 | 3228 | 0.4588 | 0.2400 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 929 | 1508 | 3228 | 0.4672 | 0.2518 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 929 | 1596 | 3228 | 0.4944 | 0.2900 |
Hs 578T | Dovitinib | 0.04 | uM | LJP5 | 1 | E24 | 72 | hr | 929 | 2405 | 3228 | 0.7450 | 0.6420 |
Hs 578T | Dovitinib | 0.04 | uM | LJP5 | 2 | E24 | 72 | hr | 929 | 2657 | 3228 | 0.8231 | 0.7516 |
Hs 578T | Dovitinib | 0.04 | uM | LJP5 | 3 | E24 | 72 | hr | 929 | 2592 | 3228 | 0.8030 | 0.7233 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 1 | D18 | 72 | hr | 929 | 3269 | 3228 | 1.0127 | 1.0178 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 2 | D18 | 72 | hr | 929 | 3349 | 3228 | 1.0375 | 1.0526 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 3 | D18 | 72 | hr | 929 | 3226 | 3228 | 0.9994 | 0.9991 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 1 | M24 | 72 | hr | 929 | 3109 | 3228 | 0.9631 | 0.9482 |